EP3658223A1 - Electrode devices for neurostimulation - Google Patents
Electrode devices for neurostimulationInfo
- Publication number
- EP3658223A1 EP3658223A1 EP18749097.4A EP18749097A EP3658223A1 EP 3658223 A1 EP3658223 A1 EP 3658223A1 EP 18749097 A EP18749097 A EP 18749097A EP 3658223 A1 EP3658223 A1 EP 3658223A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- inner flap
- flexible inner
- neural interface
- electrode
- electrodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000001537 neural effect Effects 0.000 claims abstract description 76
- 239000000463 material Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 239000002210 silicon-based material Substances 0.000 claims description 12
- 238000000465 moulding Methods 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 5
- 150000003431 steroids Chemical class 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 239000004020 conductor Substances 0.000 abstract description 14
- 238000004513 sizing Methods 0.000 abstract description 9
- 239000000758 substrate Substances 0.000 abstract description 9
- 210000005036 nerve Anatomy 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 7
- -1 polytetrafluoroethylene Polymers 0.000 description 5
- 208000028389 Nerve injury Diseases 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 210000002751 lymph Anatomy 0.000 description 4
- 230000008764 nerve damage Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920009441 perflouroethylene propylene Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229920000106 Liquid crystal polymer Polymers 0.000 description 2
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- RTACIUYXLGWTAE-UHFFFAOYSA-N buta-1,3-diene;2-methylbuta-1,3-diene;styrene Chemical compound C=CC=C.CC(=C)C=C.C=CC1=CC=CC=C1 RTACIUYXLGWTAE-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001169 hypoglossal nerve Anatomy 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004007 neuromodulation Effects 0.000 description 1
- 208000001797 obstructive sleep apnea Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0556—Cuff electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
Definitions
- the present disclosure is related to embodiments of extravascular devices containing electrodes for neurostimulation of a vessel.
- the devices are housed in flexible substrates, each substrate having a spinal portion for routing leads/conductors into the device for connection to the electrodes. Extending from opposite sides of the spinal portion is a self-sizing inner flaps that support and position the electrodes to be inward facing, i.e., extravascular designs, and one more rigid outer flaps.
- the electrodes may be flexible multifilar coil electrodes.
- Extravascular devices are arranged to be positioned on the outside of the target vessel, or at least partially.
- U.S. Pat. No. 7,231,260 discloses an intravascular device that includes a single flap with a few electrodes that can be collapsed (rolled up) to fit within a catheter for implantation, and which expands outside of the catheter to cover a portion (less than 360 degrees) of the inside walls of a target vessel.
- the flap itself may be an arcuate resilient spring formed of polyimide, polytetrafluoroethylene, fluorinated ethylene propylene, polyethylene or silicone, or include a plurality of resilient spring loops mounted to the flap to apply pressure against an opposing wall, thereby pushing the flap against the opposing target vessel wall.
- Conventional helical or serpentine electrode devices further address some of the limitations of conventional rigid cuff-like and cage-like devices, such as permitting some radial expansion that helps with post-operative edema or swelling of the target vessel, more fluid exchange with surrounding tissue, better electrical contact, and reduced growth of connective tissue.
- Helical or serpentine devices require a complex positioning that requires significant dissection and nerve manipulation in order to wind the helix around the nerve at least two times. Positioning of such devices also requires mobilization of a large portion of the nerve because the cathode and anode electrodes are typically positioned by their own device.
- Cuff-like devices require electrodes that provide maximum electrode coverage while being radially compliant.
- the term "compliant" as used herein refers to the amount of flexibility and/or give that an object might have and particularly in reference to its ability to interact with other objects. For example, when a first object puts physical pressure on a second object intended to work with the first object, the second object is compliant if it is capable of adjusting to that physical pressure, while continuing to perform its intended function.
- Conventional electrodes used for this purpose include very thin metal sheet electrodes, segmented metal contacts, and thin-film based electrodes. Thin metal sheets can be difficult to connect to leads, provide limited radial compliance and are prone to breakage if excessive stress is applied to the cuff (i.e., from opening and closing). Segmented contact electrodes increase the complexity of manufacturing the cuff and provide limited electrode coverage. Thin film based electrodes can also be difficult to interconnect to lease and are prone to delamination.
- a neural interface for interfacing with a target vessel, the neural interface comprising: a spinal portion configured to house electrical leads for one or more electrodes and configured to provide a supporting structure; a flexible inner flap connected to at least a first side of the spinal portion and configured to house and position the one or more electrodes around the target vessel; and an outer flap connected a second side of the spinal portion and configured to overlap the flexible inner flap, wherein the first side is opposite the second side, wherein the outer flap is more rigid than the flexible inner flap, wherein the outer flap and the flexible inner flap are configured to create a mechanically lock between the outer flap and the flexible inner flap.
- the neural interface is able to cover the entire circumference of the target vessel, which can improve the electrical coverage provided by the neural interface and the stability of the interface between the neural interface and the target vessel. Also, the neural interface can be positioned on the target vessel in a simple manner.
- the inner flap of the neural interface may be non-rigid and capable of elastic deformation (i.e. reversible deformation). In this way, the inner flap can be displaced from an initial resting state into a different state in order to position the interface with respect to the target vessel. The inner flap is, therefore, biased towards the initial resting state. Then, when the interface is in an appropriate position the interface can be released allowing the inner flap to be urged back to its resting state, thus softly gripping the target vessel.
- the inner flap is capable of radial flexibility.
- nerve damage may result from the decreased blood flow and constricted nerve fibers.
- Temporary swelling of the target vessel caused by the trauma of the positioning of the neural interface can exacerbate such nerve damage.
- loose fitting interfaces can result in poor electrical contact and low treatment efficiency, which can further degrade over times as a result of ingrowth of connective tissue between the target vessel and the interface.
- the outer flap is more rigid than the flexible inner flap (i.e. the outer flap is less flexible than the flexible inner flap). In this way, the outer flap provides stability while the inner flap is able to softly grip the target vessel.
- the spinal portion comprises an elongate member comprising a conduit for electrical conductors for the first electrode and the second electrode. In some examples, the spinal portion includes the electrical conductors. The spinal portion provides a simple and convenient arrangement for providing electrical connectivity to the first electrode and the second electrode.
- the one or more electrodes are housed in the flexible inner flap.
- the electrical leads may be housed in the spinal portion and may be connected to respective one or more electrodes.
- a method of manufacturing a neural interface comprising: covering a length of a lead with a tube except for a first end of the lead; connecting the first end of the lead to an elongated electrode; placing at least a portion of the length of the lead, the first end of the lead and the elongated electrode in a first mold; molding via the first mold a first material over at least the portion, the first end of the lead and the elongated electrode to create a flexible inner flap and a spinal portion of the neural interface, wherein at least a portion of a length of the elongate electrode is exposed from the first material on an inside surface of the flexible inner flap; and molding via a second mold a second material to create an outer flap of the neural interface, the outer flap covering at least a portion of the flexible inner flap, wherein the outer flap and the flexible inner flap are configured to create a mechanically lock between the outer flap and the flexible inner flap.
- a coil electrode for a neural interface comprising: a central portion extending from a proximate end of the coil electrode to a distal end; two or more filar spirally wound around the central portion from the proximate end to the distal end, wherein the two or more filar are connected to a lead for controlling the coil electrode at the proximate end; and a plug at the distal end for terminating the two or more filar.
- a vessel refers to a vessel and a nerve (or nerves) that travels along with the vessel.
- the vessel may be an artery (or arteries) and/or a vein (or veins) and/or a lymph vessel (or lymph vessels).
- a nerve that travels along a vessel may be a nerve that is adjacent to the vessel or a nerve that is in the vicinity of the vessel.
- a target vessel may be a target vessel that includes a nerve (or nerves) that travels along with the vessel.
- the target vessel may be an artery (or arteries), and/or a vein (or veins), and/or a lymph vessel (or lymph vessels).
- FIG. 1A is a perspective view of an embodiment of an extravascular neural interface device including a flexible overlapping flap structure holding and positioning a plurality of elongated elliptical (curved) electrodes;
- FIG. IB is an end view of the embodiment of FIG. 1 A;
- FIG. 2 is a side view of the embodiment of FIG. 1 A;
- FIG. 3 A, FIG. 3B and FIG. 3C illustrate a variety of different electrodes with extending wings or spikes or protruding bites for enabling the electrodes to be embedded between sheets of the flap structure;
- FIG. 4A is a perspective view of an embodiment of an extravascular neural interface device including a flexible overlapping flap structure holding and positioning coil electrodes;
- FIG. 4B is a detailed view of the interface connecting the coil electrode to the conductor
- FIG. 5 is a perspective view of the embodiment of FIG. 4A further illustrating the outer flap of the neural interface device
- FIG. 6 is a top view of the embodiment of FIG. 5;
- FIG. 7A illustrates a side view of the embodiment of FIG. 6
- FIG. 7B is a detailed view of the distal end of the coil electrode of FIG. 7A.
- FIG. 8 is a perspective view of a neural interface including a plurality of multifilar coil electrodes in accordance with an embodiment
- the present disclosure is related to embodiments of extravascular devices containing electrodes for neurostimulation of a vessel.
- the devices are housed in flexible substrates, each substrate having a spinal portion for routing leads/conductors into the device for connection to the electrodes.
- Extending from opposite sides of the spinal portion is a self-sizing inner flaps that support and position the electrodes to be inward facing, i.e., extravascular designs, and one more rigid outer flap.
- the electrodes may by flexible multifilar coil electrodes.
- self-sizing it is meant that the neural interface 100 conforms to the shape of the target vessel of its own accord.
- the neural interface 100 may comprise a self-sizing cuff 102 that is formed of a supporting substrate manufactured of silicone or a similar flexible substance (e.g., with a hardness of Shore A20 to A70, where "hardness” generally refers to a measure of how resistant solid matter is to permanent shape change when a compressive force is applied, which hardness of the material may be measured with a durometer), such as styrene isoprene butadiene (SIBS), polyamide, parylene, liquid-crystal polymer (LCP), polytetrafluoroethylene (PTFE), polyethylene (PE), polypropylene (PP), fluorinated ethylene propylene (FEP), ethyl ene-tetrafluoroethylene (ETFE), polyurethane, or another biocompatible polymer.
- SIBS styrene isoprene butadiene
- LCP liquid-crystal polymer
- PTFE polytetrafluoroethylene
- PE
- the inner flap 104 may include a spinal portion or spine 110 that houses leads or conductors for each of the electrodes.
- the flaps may be positioned orthogonal to the length of the target vessel (not shown) around which the flaps may be ultimately wrapped or may be positioned at an angle, such as 45 degrees relative to the length.
- the inner flap 104 may be wrapped around the target vessel and the outer flap 108 may then be wrapped around the inner flap 104.
- Housed and positioned within the inner flap 104 may be a series of 8 or more
- FIG. 2 illustrates the series of electrodes 120 labeled from 1 to 8, with one column of electrodes (1-4) substantially opposite, yet offset from, a second column of electrodes (5-8), while FIG. IB illustrates the resulting arrangement of the 8 electrodes from an end view.
- FIG. 1 A illustrates the series of electrodes 120 positioned to form a staggered circular ring pattern around the target vessel 112.
- the series of electrodes 120 may be positioned in a selective or non-selective layout and may include a positive left hand spiral column and a negative right hand spiral column, or may be formed in any other combination or arrangement.
- the electrodes 120 may be platinum or platinum alloy electrodes (or electrode arrays).
- the electrodes 120 may be of a conventional type and wired to a controller through conventional conductors, such as 35N LT® DFT (Drawn Filled Tubing) with a 28% Ag core, in a stranded cable configuration or in a multi-filar coil configuration.
- the conductors are housed in spinal portion or spine 110.
- the “segmented" electrode designs may provide better mechanical compliance, create the possibility of surface features, i.e., protruding electrodes, and make it possible to control each electrode individually (i.e., current steering). For example, connecting individual electrodes or different arrays of electrodes to different conductors may enable selective stimulation of the target vessel by individually controlling each connected device. Individual electrodes, if wired separately, may be selected and activated for power/current grading of a stimulation field of the target vessel. In addition, the polarity of the electrodes may be controlled independently.
- all of the electrodes in a first row of electrodes 130 may have a negative polarity while all of the electrodes in a second row of electrodes 132 may have a positive polarity, or the negative and positive polarity may be mixed in both of the rows of electrodes 130 and 132.
- the electrodes 120 may also be positioned in an overlapping fashion, such that no electrical transverse gaps are created between the electrodes in rows 130 and 132.
- the electrodes in the row 130 may be offset from the electrodes in the row 132 so as to cover at least a helical turn of the electrodes 130 when the neural interface 100 is positioned, which also prevents any transverse gaps between the rows.
- the neural interface when the neural interface is positioned on the target vessel there is no longitudinal axis/plane along the length of the interior or exterior surface of the target vessel that does not pass through an electrode over at least a 360 degree turn around an interior surface or an exterior surface of a target vessel.
- Aligning individual electrodes or arrays of electrodes so as to remove electrical transverse gaps, say between two rows of electrodes or some other arrangement, may insure complete electrical coverage of the target vessel over a length of the target vessel.
- a total of 8 coiled platinum electrode rows or strips may be utilized in each neural interface.
- Neural interface 100 may also be configured for intravascular applications by locating the electrodes along exterior surfaces of the neural interface 100.
- Other electrode shapes may also be used.
- each of the substantially circular electrodes 300 and the substantially elliptical curved electrodes 302 are further illustrated in FIG. 3A and FIG. 3B, respectively. As illustrated in FIG.
- each electrode 300 may include a plurality of wings 304 that may include a number of holes/bites/protrusions in each wing.
- the inner flap 104 may be manufactured from sheets of substrate material.
- the electrode 300 may be connected to lead wired 310 and positioned on a first sheet of the inner flap 104. Glue or silicone may be used to fill the holes of the wings 304 before a second sheet is applied over the top.
- the electrodes 300 may be positioned on a sheet and have a second sheet reflowed over the top to fill the holes of the wings. Sheet material covering the electrodes may be laser ablated, if necessary, to expose the surface of the electrode.
- the first or second sheet may have holes preformed in the sheet to indicate the position of each electrode and to expose the surface of the electrode, as necessary, relative to the second sheet.
- each electrode 302 may include a plurality of wings 308 that may include a number of holes/bites/protrusion in each wing.
- the inner flap 104 may be manufactured from sheets of substrate material.
- the electrode 302 may be connected to lead wired 312 and positioned on a first sheet of the inner flap 104. Glue or silicone may be used to fill the holes of the wings 308 before a second sheet is applied over the top.
- the electrodes 302 may be positioned on a sheet and have a second sheet reflowed over the top to fill the holes of the wings. Sheet material covering the electrodes may be laser ablated, if necessary, to expose the surface of the electrode.
- the first or second sheet may have holes preformed in the sheet to indicate the position of each electrode and to expose the surface of the electrode, as necessary, relative to the second sheet.
- each substantially circular electrode 350 has a substantially circular ring 352, essentially a continuous wing, attached to and positioned around the electrode 350.
- the ring 352 includes a number of holes 354 around the ring 352, which may be filled with glue or silicone, as discussed above, in order to hold the electrode 350 in position within the inner flap 356.
- the lead wires from each electrode may be routed through the sheets of the inner flap to a spinal portion or spine.
- the leads 360 of each electrode 350 is routed in-between the sheets of the inner flap 356 to spinal portion or spine 362 and then away from the device to a controller (not shown).
- the overlapping flaps of the cuff of the neural interface may also be manufactured with coil electrodes, further illustrated with reference.
- FIG. 4A illustrates a cuff 400 of an
- the cuff 400 may include an inner flap 402 and an outer flap 404 connected to a spinal portion or spine 406.
- the spine 406 may include a silicone tubing 407 through which the leads/conductors of the electrodes may be housed and routed, with the individual leads 409 for each electrode exiting a distal end of the tubing 407.
- the circled area 410 of FIG. 4 A is further illustrated in FIG. 4B.
- the lead 409 may by connected to the coil electrode 420 by a crimp/weld sleeve 424.
- the electrode 420, sleeve 424, conductor 408, lead 409 and tubing 407 may be preassembled and positioned within a mold prior to formation of the remainder of the cuff 400. Once those components are positioned in the mold, the inner flap 402 and the spinal portion or spine 406 may be molded over those components. In an embodiment, inner flap 402 and spinal portion or spine 406 may be molded at a shore hardness of approximately 20A so as to be compliant and self-sizing. In an embodiment, after molding the inner flap 402, the outer flap 404, which is further illustrated in FIG. 5, may be molded at a shore hardness of approximately 75A. As shown in FIG.
- the outer flap 404 may include a set of holes 430 through which protrusions 432 formed in the molding of inner flap 402 may be inserted.
- a portion of the inner flap 402, sufficient to support the protrusions 432 may be formed on a first side of the spinal portion/spine 406 while the remainder of the inner flap is formed on the second (opposite) side of the spinal portion/spine 406.
- the outer flap 404 may then be formed on the first side over the portion of the inner flap 402 on that same side, with the protrusion extending through the holes 430, which is configured to enable the inner flap 402 to be mechanically locked to the more rigid outer flab 404.
- the shore hardness referred to above may be measured with a durometer.
- the mechanical lock is provided by protrusions and holes; however, it will be appreciated that the mechanical lock could be provided by another suitable arrangement that would be apparent to the skilled person.
- the electrodes 420 may be positioned in a central area of the cuff 400 and spaced appropriately from one another. As further Illustrated in FIG. 7A, the electrode 420 may be exposed at the interior surface of the inner flap 402 (i.e., only partially embedded, hence slightly protruding) so as to make good contact with the surface of the target vessel and largely follow the along the width of the inner flap 402.
- the topology of the surface of the electrode 420 leads to a greater active surface of the electrode 420 compared to conventional flat electrodes. For instance, for the same footprint, a coil electrode can provide two times more exposed electrode surface.
- the electrodes 420 may include one or more filars 438 wrapped in a coil around a central portion 440 and terminated at a laser welded plug 442.
- the number of filars 438 involves a trade-off between the electrode compliance and electrical resistance of the electrode 406. Increasing the number of filars 438 decreases the radial compliance of the electrode 406 while decreasing the electrode's electrical resistance.
- Each filar 438 within the electrode 420 may be assigned the same polarity or different polarities.
- a neural interface 800 may include a plurality of multifilar coil electrodes 802 and 804, each of which may have the same or different polarities.
- each of the individual filar 806 wrapped around the central portion of each coil electrode 802 and 804 may be configured to have the same or different polarities and individually controlled (including the ability to change polarity when desired), thereby enabling the filar 806 and the coil electrodes 802 and 804 to be selectively stimulated.
- the polarity of any electrode can be determined by a controller (not shown) providing power to the electrode and is not necessarily dependent on a mechanical structure of an electrode to determine that electrode's polarity.
- the electrodes can be configured to have a specific polarity and configured for that polarity to be changed.
- an electrode could be configured to have a selective negative polarity, i.e., negative polarity is selected, and then be configured, at a later point in time, to have a selective positive polarity.
- inner flap 402 which may be molded from silicone or a similar material, is configured such as to allow the inner flap 402 to self-size to target vessels of varying radial width, yet maintain close to 360 degree coverage of the surface of the target vessel.
- the electrodes 420, 802 and 804 may be longitudinally compliant so they can adjust to the self-sizing inner flap. Longitudinal compliance may be achieved by wrapping the filar around the central portion so that the filar can move along the length of the central portion, like a wound spring, as the inner flap moves.
- the coil electrodes 420, 802 and 804 may at least as flexible as the flexible inner flap, or less flexible than the flexible inner flap. In either case, the coil electrode may be longitudinally compliant.
- the material used to mold the inner flap 402 may be doped with a steroid drug, such as dexamethasone.
- a steroid drug such as dexamethasone.
- outer surface of the cuff 00 may also, or alternatively, be coated with a hydrophilic polymer, such as poly-2-hydroeyethyl-methacrylate (pHEMA).
- pHEMA poly-2-hydroeyethyl-methacrylate
- the resulting cuff 400 provides excellent radial compliance because the coil electrode 406 is designed to be as compliant as the material of the inner flap 402, thereby reducing flex fatigue and a tendency to kink or wrinkle as may be the case with conventional electrodes.
- the coil electrode 406 may stretch and therefore provide a lower radial force, thereby reducing pressure on the nerves of the target vessel.
- the extended length of the coil electrode 406 and its position within the inner flap 402 of the cuff 400 maximize circumferential coverage and active surface coverage. This reduces the need to segment the electrodes in order to increase compliance.
- the conductors can be easily connected to the electrodes and is easy to manufacture.
- a neural interface comprising:
- a spinal portion configured to house electrical leads for one or more electrodes and provide a supporting structure
- a flexible inner flap connected to at least a first side of the spinal portion and configured to house and position the one or more electrodes around a target vessel;
- an outer flap connected a second side of the spinal portion and configured to overlap the flexible inner flap, wherein the first side is opposite the second side, wherein the outer flap is more rigid than the flexible inner flap, wherein the outer flap and the flexible inner flap are configured to create a mechanically lock between the outer flap and the flexible inner flap.
- a first portion of the flexible inner flap is connected to the second side of the spinal portion and includes one or more protrusions on an outer surface of the first portion, wherein a second portion of the flexible inner flap is connect to the first side of the spinal portion and includes the one or more electrodes, and wherein one or more holes are formed in the outer flap and configured to receive the one or more protrusions.
- a method of manufacturing a neural interface comprising: covering a length of a lead with a tube except for a distal end of the lead; connecting the distal end of the lead to an elongated electrode;
- the coil electrode includes one or more filar wound around a central portion and terminated at a distal end of the central portion at a plug.
- a coil electrode for a neural interface comprising:
- a central portion extending from a proximate end of the coil electrode to a distal end; two or more filar spirally wound around the central portion from the proximate end to the distal end, wherein the two or more filar are connected to a lead for controlling the coil electrode at the proximate end; and
- the flexible inner flap includes at least two coil electrodes, one of which is configured to have a positive polarity and one of which is configured to have a negative polarity.
- a neural interface comprising:
- a flexible inner flap configured to positioned completely around a target vessel
- At least one coil electrode including one or more filar spirally wound around a central electrode portion from a proximate end to substantially near a distal end of the central electrode portion, wherein the one or more filar are connected to a lead for controlling the at least one coil electrode, wherein the at least one coil electrode is partially embedded in the flexible inner flap, and wherein the at least one coil electrode includes a plug at the distal end of the central electrode portion for terminating the one or more filar.
- the flexible inner flap includes at least two coil electrodes, one of which is configured to have a positive polarity and one of which is configured to have a negative polarity.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762538434P | 2017-07-28 | 2017-07-28 | |
PCT/GB2018/052077 WO2019020986A1 (en) | 2017-07-28 | 2018-07-23 | Electrode devices for neurostimulation |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3658223A1 true EP3658223A1 (en) | 2020-06-03 |
Family
ID=63077903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18749097.4A Withdrawn EP3658223A1 (en) | 2017-07-28 | 2018-07-23 | Electrode devices for neurostimulation |
Country Status (3)
Country | Link |
---|---|
US (2) | US11559692B2 (en) |
EP (1) | EP3658223A1 (en) |
WO (1) | WO2019020986A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8934992B2 (en) | 2011-09-01 | 2015-01-13 | Inspire Medical Systems, Inc. | Nerve cuff |
US11298540B2 (en) | 2017-08-11 | 2022-04-12 | Inspire Medical Systems, Inc. | Cuff electrode |
EP3965871A4 (en) * | 2019-05-10 | 2023-01-25 | Galvani Bioelectronics Limited | Methods to reduce flashes on electrodes |
US11883650B1 (en) * | 2019-06-25 | 2024-01-30 | Verily Life Sciences, LLC | Bi-layered neural interface with nerve-facing drug eluting structure |
US20220409888A1 (en) | 2019-11-27 | 2022-12-29 | Galvani Bioelectronics Limited | Electrode devices for neurostimulation and related methods |
US20240108883A1 (en) * | 2022-09-29 | 2024-04-04 | The Alfred E. Mann Foundation For Scientific Research | Electrode leads having nerve cuffs and associated systems and methods |
CN116473562A (en) * | 2023-06-21 | 2023-07-25 | 博睿康科技(常州)股份有限公司 | Intelligent electrode and manufacturing method thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5003992A (en) * | 1989-08-23 | 1991-04-02 | Holleman Timothy W | Atraumatic screw-in lead |
US5938596A (en) * | 1997-03-17 | 1999-08-17 | Medtronic, Inc. | Medical electrical lead |
DE19847446B4 (en) * | 1998-10-08 | 2010-04-22 | Biotronik Gmbh & Co. Kg | Nerve electrode assembly |
US6181971B1 (en) | 1998-12-09 | 2001-01-30 | Pacesetter, Inc. | Joining conductor cables and electrodes on a multi-lumen lead body |
US8145316B2 (en) | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8412348B2 (en) | 2004-05-06 | 2013-04-02 | Boston Scientific Neuromodulation Corporation | Intravascular self-anchoring integrated tubular electrode body |
US7676275B1 (en) | 2005-05-02 | 2010-03-09 | Pacesetter, Inc. | Endovascular lead for chronic nerve stimulation |
US7809442B2 (en) | 2006-10-13 | 2010-10-05 | Apnex Medical, Inc. | Obstructive sleep apnea treatment devices, systems and methods |
US20080147158A1 (en) * | 2006-12-18 | 2008-06-19 | Quan Emerteq Corp. | Implantable Medical Lead Having Coil Electrode |
US8155757B1 (en) | 2007-07-26 | 2012-04-10 | Advanced Neuromodulation Systems, Inc. | Cuff electrode having tubular body with controlled closing force |
US9572982B2 (en) | 2008-04-30 | 2017-02-21 | Medtronic, Inc. | Techniques for placing medical leads for electrical stimulation of nerve tissue |
BRPI0920548B8 (en) | 2008-10-09 | 2021-06-22 | Imthera Medical Inc | device to control the position of a patient's tongue |
US8515520B2 (en) * | 2008-12-08 | 2013-08-20 | Medtronic Xomed, Inc. | Nerve electrode |
US20100268311A1 (en) | 2009-04-17 | 2010-10-21 | Ralph Cardinal | Method for Implanting Electrode on Nerve |
BR112012010986A2 (en) | 2009-11-10 | 2016-04-12 | Imthera Medical Inc | system to stimulate a hypoglossal nerve to control a patient's tongue position |
EP2595696B1 (en) | 2010-07-19 | 2018-05-16 | Cardiac Pacemakers, Inc. | Minimally invasive lead system for vagus nerve stimulation |
US8886335B2 (en) | 2011-12-07 | 2014-11-11 | Boston Scientific Neuromodulation Corporation | Implantable leads with a low profile distal portion |
US20130289686A1 (en) | 2012-04-29 | 2013-10-31 | Synecor Llc | Intravascular electrode arrays for neuromodulation |
US9555234B2 (en) * | 2012-07-26 | 2017-01-31 | Medtronic, Inc. | Implantable medical leads |
EP2938396B1 (en) | 2012-12-28 | 2017-02-22 | Cardiac Pacemakers, Inc. | Stimulation cuff and implantation tool |
-
2018
- 2018-07-23 EP EP18749097.4A patent/EP3658223A1/en not_active Withdrawn
- 2018-07-23 US US16/634,620 patent/US11559692B2/en active Active
- 2018-07-23 WO PCT/GB2018/052077 patent/WO2019020986A1/en active Application Filing
-
2022
- 2022-12-22 US US18/145,780 patent/US20230125962A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20200230421A1 (en) | 2020-07-23 |
WO2019020986A1 (en) | 2019-01-31 |
US11559692B2 (en) | 2023-01-24 |
US20230125962A1 (en) | 2023-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230125962A1 (en) | Electrode devices for neurostimulation | |
US11944812B2 (en) | Electrode devices for neurostimulation | |
US20180207419A1 (en) | Implantable flexible circuit leads and methods of use | |
EP3595768B1 (en) | Electrode devices for neurostimulation | |
US20130289686A1 (en) | Intravascular electrode arrays for neuromodulation | |
US8954167B2 (en) | Helically formed coil for a neural cuff electrode | |
US11395921B2 (en) | Intravascular electrode arrays for neuromodulation | |
JP6069507B2 (en) | Fixation mechanism for temporary implantable electrical stimulation leads | |
AU2014290582B2 (en) | Multi-electrode lead with backing for mecho/baroreceptor stimulation | |
US11395915B2 (en) | Electrode devices and methods of manufacturing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200219 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20210302 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230511 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20230922 |